On August 5, 2020, ORIENT BIO Inc. (KOSE:A002630) closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
532 KRW | +1.14% | +2.31% | -12.36% |
1st Jan change | Capi. | |
---|---|---|
-12.36% | 45.61M | |
+3.92% | 111B | |
+11.48% | 105B | |
-13.05% | 22.34B | |
-3.70% | 21.93B | |
-6.03% | 18.59B | |
-35.21% | 18.12B | |
-10.29% | 16.96B | |
+2.46% | 13.7B | |
+35.98% | 12.45B |
- Stock Market
- Equities
- A002630 Stock
- News ORIENT BIO Inc.
- ORIENT BIO Inc. announced that it has received KRW 11.67259512 billion in funding from MDAS Inc., Orient Precision Industries Inc.